Multiple pathways drive the sterile injury response in the liver; however, it is unclear how the type of cells injured or the mechanism of injury activates these pathways. Here, we use a model of selective hepatocyte death to investigate sterile liver injury. In this model, the TIR-domain-containing adaptor-inducing interferon-b (TRIF) was a central mediator of the resulting intrahepatic inflammatory response that was independent of both upstream Toll-like receptor (TLR) 4 signaling and downstream type I interferon (IFN) signaling. TRIF was required for induction of interleukin (IL)-10, IL-6, and IL1b cytokines. Conversely, although induction of C-C motif chemokine ligand (CCL) 2 and C-X-C motif chemokine ligand (CXCL) 1 chemokines and up-regulation of chemokine (Ccl2, Ccl7, Cxcl1, Cxcl2, and Cxcl10) and cell-adhesion (intracellular adhesion molecule 1 and vascular cell adhesion molecule 1) genes involved in myeloid cell recruitment was reduced in a majority of TRIF -/-mice, a subset of TRIF -/-mice showed breakthrough inflammation and the ability to induce these genes and proteins, indicating that redundant pathways exist to respond to hepatocyte death. Furthermore, we found that hepatocytes themselves were the main responders to hepatocyte death, increasing transcription of genes involved in myeloid cell recruitment more than either liver sinusoidal endothelial cells or Kupffer cells. Conclusion: Our studies define a TRIF-dependent, TLR4-and type I IFN-independent pathway of sterile liver injury in which hepatocytes are both the targets of damage and the principal responding cell type. (HEPATOLOGY 2017;65:1336-1351).
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T issue damage generally induces a robust sterile inflammatory response comprised of increased production of inflammatory mediators and recruitment of neutrophils and monocytes to the site of injury.
(1) When the sterile inflammatory response is short-lived, the tissue recovers; however, the response may also produce persistent inflammation, which, in the liver, can lead to fibrosis, cirrhosis, and hepatocellular carcinoma. (2, 3) Drug-induced damage (e.g. acetaminophen [APAP] hepatotoxicity), alcoholic steatohepatitis, diet-induced damage (nonalcoholic steatohepatitis), and mechanically induced damage (ischemia-reperfusion injury) all promote cell death within the liver.
Damage-associated molecular patterns (DAMPs) released from dying cells signal through the same Abbreviations: ALT, alanine aminotransferase; APAP, acetaminophen; CCL, C-C motif chemokine ligand; CCR2, C-C chemokine receptor type 2; CXCL, C-X-C motif chemokine ligand; DAMPs, damage-associated molecular patterns; DRGs, DNAse-resistant genomes; DT, diphtheria toxin; hDTR, human diphtheria toxin receptor; IFN, interferon; IFNAR1, interferon (alpha and beta) receptor 1; Icam1, intracellular adhesion molecule 1; Ifnb1, Ifn-beta; IL, interleukin; KC, Kupffer cell; LSEC, liver sinusoidal endothelial cell; MyD88, myeloid differentiation primary response gene 88; NF-jB, nuclear factor kappa B; PBS, phosphate buffered saline; rAAV, recombinant adeno-associated virus; TLR, Toll-like receptor; TNF-a, tumor necrosis factor alpha; TRIF, TIR-domain-containing adaptor-inducing interferon-b; Vcam1, vascular cell adhesion molecule 1. pattern recognition receptors that recognize pathogenassociated molecular patterns to initiate the inflammatory response. (1) Though there are multiple families of pattern recognition receptors that bind DAMPs, Tolllike receptors (TLRs) are an important class of pattern recognition receptors in the sensing of sterile liver injury. Multiple mouse models of sterile inflammation have shown a central role for signaling through TLRs and their downstream effectors, TIR-domain-containing adaptor-inducing interferon-b (TRIF) and myeloid differentiation primary-response gene 88 (MyD88).
Models of sterile inflammation in the liver have provided key insights about the inflammatory pathways involved in the response to liver damage. There exists, however, a knowledge gap concerning the sterile inflammatory response to the death of each specific cell type. Models of toxic liver injury result in complexity that is challenging to analyze. For example, in APAPmediated toxicity, injury to liver sinusoidal endothelial cells (LSECs) and disruption of the microvasculature precedes necrosis of hepatocytes, occurring as early as 30 minutes after drug administration. (4) In concanavalin A-induced hepatitis, LSECs are eliminated early in the pathology by CD4
1 T cells, destroying the lining and exposing hepatocytes to activated T cells. (5) Additionally, the concanavalin A model of hepatitis relies on components of the adaptive immune system, activated T cells, to induce hepatic damage, further complicating efforts to study the response of the innate immune system. (6, 7) Models of ischemia-reperfusion produce no clearer results as the death of both LSECs and hepatocytes occurs. (8) Inflammation in response to cell death is critically important in the liver not only in situations of drug-, diet-, and mechanically induced damage, but also in the context of infection, where inflammation is complicated by responses to host cell death and pathogen. Separating the different pathways of inflammationthose against pathogen versus those against host cell death-may prove essential to address inflammatory liver disease. In particular, the response to hepatocyte death is critical to understand given that it is a central component of both damage induced by infectious and noninfectious insults.
We have, therefore, developed a mouse model to study sterile liver inflammation initiated by hepatocytespecific death. We found that TRIF, independent of TLR4 and type I interferon (IFN) signaling, plays a key role in the initiation of sterile inflammation, of which hepatocytes themselves are major regulators. 
Materials and Methods

MICE
OTHER MATERIALS AND METHODS
Additional materials and methods are described in the Supporting Materials and Methods.
Results
MODEL OF HEPATOCYTE-SPECIFIC DEATH
To identify pathways of sterile inflammation in the liver, we developed a mouse model of hepatocytespecific death. We designed an rAAV vector encoding the fluorescent reporter protein, mCherry, and the hDTR, rAAV8.pAlb.mCherry.hDTR (Fig. 1A) . This vector uses the AAV serotype-8 capsid proteins to preferentially target to the liver (Fig. 1B ) and the mouse a-fetoprotein enhancer in combination with the albumin promoter for hepatocyte-specific expression of transgenes (Fig. 1C,D) . Mice received 5 3 10 9 DRGs of vector by retro-orbital injection. After allowing 2 weeks for vector expression to stabilize within the mouse, we induced hepatocyte death by injection of DT. Liver damage, measured by alanine aminotransferase (ALT) levels, peaked at 48 hours (Fig. 1E) .
Histological examination showed the presence of a cellular infiltrate, as well as extensive hepatocyte necrosis, by 48 hours (Fig. 1F) . Hepatocytes undergoing mitosis, indicative of tissue repair, appeared by 48 hours (arrow, Fig. 1F ). By 72 hours, the infiltrate had increased and there were increased numbers of mitotic hepatocytes, indicating further tissue repair, though there still remained evidence of dying hepatocytes. Immunofluorescence showed strong and diffuse mCherry expression limited to the cytoplasm of hepatocytes in the control group. By 24 hours and continuing to 48 hours post-DT administration, the mCherry signal was consolidating into round vacuoles largely within the cytoplasm of hepatocytes, but also within cells in the sinusoids. By 72 hours, large vacuoles of mCherry signal were less concentrated in hepatocytes, with smaller puncta of mCherry signal appearing throughout the cytoplasm of hepatocytes and within cells in the sinusoids. Taken together, these observations suggest the occurrence of either autophagy within dying cells or phagocytosis of dying cells by hepatocytes and other nonparenchymal cells within the liver. To investigate further the mechanism of DT-induced hepatocyte death, we used an Huh7 hepatoma cell line that stably expresses TLR3 (Huh7-TLR3) as well as RIPK3 -/-mice. These analyses suggest that DT kills hepatocytes in a caspase 3/7-independent, nonnecroptic manner (Supporting Fig. S1 ).
To assess whether our hepatocyte-targeted model of acute liver injury aligned with a more physiological, but less-targeted, model, such as APAP-induced liver injury, we measured a broad panel of transcriptional changes in response to both mechanisms of damage. Analysis of cellular infiltrate and gene expression indicated that both models produce similar changes in gene expression at peak injury (Supporting Fig. S2) , suggesting that our model of hepatocyte-specific death may allow us to resolve mechanisms of injury that are potentially obscured in a more-complex context.
NEUTROPHILS AND MONOCYTES ARE RECRUITED TO THE LIVER FOLLOWING HEPATOCYTE DEATH BUT DO NOT CONTRIBUTE TO LIVER INJURY
Sterile inflammation, and APAP-induced liver injury in particular, is characterized by a neutrophil and monocyte infiltrate. (10, 11) To determine whether monocytes and neutrophils infiltrated the liver in response to hepatocyte death, we used flow cytometry to assess the populations present in the liver in control mice and at 6, 12, 24, 48, 72, and 96 hours after injection of DT. Following doublet exclusion and size gating (Supporting Fig. S3 Several studies suggest that neutrophils and/or monocytes may contribute to damage in APAP liver injury models. (12) This led us to ask whether monocytes or neutrophils contributed to peak liver injury following hepatocyte death. To address this question, we used anti-CCR2 (C-C chemokine receptor type 2) and anti-Ly6G antibody to deplete monocytes and neutrophils, respectively, before, during, and following the administration of DT (Supporting Figs. S4A and S5A). Antibody-mediated depletion of monocytes reduced the number of monocytes in the liver without affecting the number of neutrophils (Supporting Fig.  S4B-D) , and antibody-mediated depletion of neutrophils reduced the number of neutrophils in the liver without affecting the number of monocytes (Supporting Fig. S5B-D) . Forty-eight hours following DT administration, neither monocyte-depleted nor neutrophil-depleted mice showed a difference in ALT levels compared to control mice (Supporting Figs. S4E and S5E), indicating that monocytes and neutrophils are not mediators of peak liver injury. This does not rule out the possibility that monocytes and/or neutrophils contribute to liver injury either before or after peak injury.
THE INDUCTION OF GENES INVOLVED IN MONOCYTE AND NEUTROPHIL RECRUITMENT IS STRONGEST IN HEPATOCYTES
The presence of neutrophils and monocytes caused us to ask whether chemokines and adhesion molecules involved in myeloid cell recruitment were induced as a component of the inflammatory response against hepatocyte death. To examine this, we looked at the expression of chemokine genes in total liver, hepatocytes, LSECs, and KCs 6, 12, 24, 48, 72, and 96 hours following DT administration. Genes for monocyterecruiting chemokines (C-C motif chemokine ligand [Ccl] 2, Ccl5, Ccl7, C-X-C motif chemokine ligand [Cxcl]10), neutrophil-recruiting chemokines (Cxcl1, Cxcl2), and adhesion molecules (intracellular adhesion molecule 1 [Icam1], vascular cell adhesion molecule 1 [Vcam1]) were strongly induced across all populations (Fig. 3A) . For Ccl7 expression in hepatocytes, levels of transcript were not detectable in 3 of 4 control mice; however, Ccl7 transcript levels were induced by 12 hours and increased by 24 hours in hepatocytes (Fig.  3B) . Induction was greatest in the hepatocytes for almost all genes measured and peaked at 24 hours. Examination of the relative expression levels between hepatocytes, LSECs, and KCs revealed that KCs generally expressed the highest levels of transcript in control mice, with the notable exception that hepatocytes expressed the most Cxcl1 (Fig. 3B) . Upon hepatocyte death, however, hepatocytes increased the level of gene expression for Ccl2, Cxcl2, Cxcl10, and Icam1 so that it surpassed that of LSECs and KCs, further suggesting that hepatocytes are the central responding cell (Fig. 3B) .
THE IMMUNE RESPONSE FOLLOWING HEPATOCYTE DEATH IS TRIF-DEPENDENT BUT TLR4-AND TYPE I IFN-INDEPENDENT
The cytokine profile suggested the involvement of type I IFN signaling, which has been shown to induce Ccl2 in mouse models of liver inflammation. (13) 0 and 3 0 ITRs. Two weeks following rAAV injection, mice received either no injection, 13 PBS (control), or DT and were sacrificed 6, 12, 24, 48, 72, or 96 hours later. hDTR mRNA levels, relative to (B) Gapdh in organs and (C) Hprt in total liver and liver cell populations of C57BL/6NJ mice that received 13 PBS, each data point represents an individual mouse (n 5 5). (D) Western blotting detection of mCherry, hDTR, and b-actin in hepatocytes of C57BL/6J mice that did not receive rAAV and in C57BL/6J and C57BL/6NJ mice that received rAAV and 13 PBS. (E) Serum ALT levels in C57BL/6J mice that received no DT or DT. Each data point represents an individual mouse, bars represent the median. (F, top row) Paraffinembedded sections stained for hematoxylin and eosin, 1003. Bar, 50 lm. Arrow, mitotic hepatocytes. (F, middle and bottom rows) Cryo-preserved sections with mCherry (top) or the merge of mCherry fluorescence (red), hepatocyte autofluorescence (green), and DAPI to distinguish nuclei (blue) (bottom). Bar, 50 lm. (D-F) are combined from two experiments (n 5 4-6 per group). Representative images chosen from 1 mouse at each time point for (F), based on median ALT levels. Significance determined by a KruskalWallis test followed by Dunn's post-test (C) of liver, LSEC, and KC to hepatocytes and (E) of each time point to the No DT group median. *Represents significance compared to No DT group; *P 0.05; **P 0.01; ***P 0.001; nonsignificance represented by absence of bar or asterisk. Abbreviations: AFP E , AFP enhancer; Alb P , albumin promoter; DAPI, 4 0 ,6-diamidino-2-phenylindole; Gapdh, glyceraldehyde-3-phosphate dehydrogenase; Hepa; hepatocyte; hDTR, human diphtheria toxin receptor; Hprt, hypoxanthineguanine phosphoribosyltransferase; IGL, inguinal lymph nodes; ITR, inverted terminal repeats; KC, Kupffer cell; LNs, lymph nodes; LSEC, liver sinusoidal endothelial cell; ND, nondetect; Sm. Int., small intestine. expression analysis indicated that Ifn-beta (Ifnb1), the main downstream effector of TRIF, was strongly induced in total liver 24 hours following liver injury, whereas transcripts driven by MyD88-dependent signaling showed more-modest induction (Supporting Fig. S6 ). The preferential induction of Ifnb1 over MyD88-driven cytokines indicated that the inflammation could be controlled by TRIF-dependent, IFNdependent signaling. To address this, we induced hepatocyte death in TRIF -/-and MyD88 -/-mice and measured the response at 48 hours, the time point when ALT levels peaked in the time course. Both TRIF -/-and MyD88 -/-mice showed significantly reduced elevation in ALT and neutrophil infiltrate compared to wild-type mice (Fig. 4A,C) ; however, only TRIF -/-mice showed a significant reduction in the influx of monocytes (Fig. 4B) . Although we found that the influx of neutrophils required MyD88, MyD88 -/-mice were only partially protected from liver damage, further suggesting that neutrophils do not play a role in liver damage. Overall, the magnitude of the effects on ALT and monocyte levels was more dramatic in the case of TRIF -/-mice. The literature indicates that signaling through TRIF activates IFN-regulatory factor 3, which drives expression of type I IFN, and particularly of IFN-b. (14) The large induction of Ifnb1 suggested to us that type I IFN signaling may be driving inflammation downstream of TRIF-mediated signaling. To test this, we induced hepatocyte death in IFNAR1 -/-mice and measured the response 48 hours after DT administration. IFNAR1
-/-mice responded to hepatocyte death with the same increases in ALT, neutrophil infiltrate, and monocyte infiltrate as wild-type mice (Fig. 4A-C suggesting that type I IFN signaling following hepatocyte death does not propagate liver damage despite the up-regulation of Ifnb1 in total liver.
Finally, to determine which receptor was responsible for initiating the inflammation to hepatocyte death, we examined the response to hepatocyte death in TLR4 -/-and TLR3 -/-mice at 48 hours following DT administration, given that TRIF is the common signaling adaptor for TLR3 and TLR4. (15) ALT levels, neutrophil infiltrate, and monocyte infiltrate were induced to comparable levels in wild-type and TLR4 -/-mice ( Fig.  4A-C) . Although this suggests that TLR3 is the DAMP receptor, we were unable to test this decisively, because TLR3 -/-mice were not transduced to equal levels by the rAAV8.mCherry.hDTR vector. Therefore, although we obtained very low ALT levels in DT-treated, vector-transduced TLR3 -/-mice, this result could not be interpreted (data not shown). Preliminary studies using the Huh7 hepatoma cell line, which lacks TLR3, show that a subset of the genes up-regulated in wild-type mice following DT-induced death are also up-regulated in Huh7 cells, suggesting that TLR3 may not be required for this TRIFdependent signaling pathway (Supporting Fig. S7 ).
ABSENCE OF TRIF RESULTS IN REDUCED PRODUCTION OF MYELOID CELL-RECRUITING FACTORS, EXCEPT IN MICE EXHIBITING BREAKTHROUGH INFLAMMATION
Given that TRIF -/-mice exhibited reduced monocyte and neutrophil infiltrate, we next asked whether up-regulation of monocyte-and neutrophil-recruiting genes was also impaired in TRIF -/-mice. At 48 hours following injection of DT, TRIF -/-mice showed less induction of Ccl2, Ccl5, Ccl7, Cxcl1, Cxcl2, Cxcl10, Icam1, and Vcam1 transcripts in total liver when -/-mice 48 hours following injection of 13 PBS or DT. Data are combined for three independent TRIF -/-experiments, three independent MyD88 -/-experiments, three independent IFNAR1 -/-experiments, and two independent TLR4 -/-experiments. The B6 mice used in the third repetition of the IFNAR1 -/-experiments were also used for the third repetition of the MyD88 -/-experiments, so the data appear twice (n 5 4, B6 1 PBS and B6 1 DT groups). Each data point represents an individual mouse (n 5 8-15 per group), bars represent the median. Significance determined by four pair-wise Mann-Whitney tests and the P values adjusted for multiple comparisons using the Holm-Bonferroni method as described in the Materials and Methods. *P 0.05; **P 0.01; ***P 0.001; nonsignificance represented by absence of bar.
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compared to wild-type mice; and though not statistically significant for all transcripts, these transcripts also trended toward reduction in hepatocytes (Fig. 5A,C) .
Examination of serum for CCL2 and CXCL1 revealed that both chemokines were significantly reduced in TRIF -/-mice compared to wild-type mice ( Figure 5D ).
FIG. 5 BREMPELIS ET AL. HEPATOLOGY, April 2017
Whereas TRIF deficiency resulted in reduced inflammation in a majority of mice as measured by ALT levels, cellular infiltrate, mRNA levels, and protein levels, we observed a subset of TRIF -/-mice that appeared to experience breakthrough inflammation. We hypothesized that total liver mRNA and serum protein levels would increase with increasing liver injury in TRIF -/-mice. To test this hypothesis, we correlated cellular infiltrate, total liver mRNA, and serum protein levels to serum ALT levels in DT-treated TRIF -/-and wild-type mice. We found that Ccl2, Ccl7, Cxcl1, Cxcl10, Icam1, and Vcam1 mRNA and CCL2 and CXCL2 protein were significantly correlated with ALT and that often the correlation was stronger in TRIF -/-than in wild-type mice (Fig. 5B,E ). These findings suggest that an alternate mechanism or mediator of inflammation, such as MyD88, compensates for the lack of TRIF in a subset of mice. Monocyte infiltrate correlated with increasing ALT; however, neutrophil infiltrate was not significantly correlated with increasing ALT levels (Fig. 5F ). The lack of neutrophil correlation with ALT level could be a result of measuring at 48 hours rather than an earlier time point, given that we found neutrophils to begin infiltrating liver earlier than monocytes (Fig. 2B) .
TRIF IS REQUIRED FOR INCREASED PRODUCTION OF INTERLEUKIN-1b, INTERLEUKIN-10, and INTERLEUKIN-6
The inflammatory cytokines, tumor necrosis factor alpha (TNF-a), interleukin (IL)-1b, and IL-6, and the anti-inflammatory cytokine, IL-10, are commonly produced in response to acute liver injury. (10) We evaluated the levels of these cytokines in serum from wild-type mice and TRIF -/-mice 48 hours following DT injection. Production of IL-10, IL-6, IL-1b, and TNF-a was reduced in TRIF -/-mice, compared to wild-type mice, 48 hours following DT injection (Fig.  6A) . Correlation of cytokine and ALT levels in serum from DT-treated mice demonstrated that whereas TNF-a correlated weakly, IL-10, IL-6, and IL-1b did not correlate with increasing liver injury in TRIF -/-mice (Fig. 6B) . This suggests that production of IL-10, IL-6, and IL-1b following hepatocyte death requires TRIF, whereas induction of TNF-a follows the same pattern as the myeloid cell-recruiting factors.
Discussion
Hepatocyte death is a key component of both pathogen-and sterile injury-induced pathologies and contributes to the development of chronic liver disease. The inflammatory circuits that respond to host death and pathogen insult overlap extensively, and models of sterile inflammation help to isolate the signaling pathways involved by removing the responses to pathogen. Though there are many mouse models of sterile liver injury, there is a lack of models to identify pathways unique to the response initiated by DAMPs released from dying hepatocytes.
We developed a mouse model of hepatocyte-specific death using an rAAV8 vector to target the hDTR construct to hepatocytes for expression. rAAV8 vectors, containing AAV2 serotype DNA and AAV8 serotype capsid proteins, are optimized for delivery of transgenes to hepatocytes. Unlike rAAV2 vectors, which achieve transduction of only 10% of hepatocytes even at high doses, rAAV8 is more efficient at transducing hepatocytes and can transduce up to 100% of hepatocytes. (16) Examination of the expression pattern of Ccl2 has one nondetect value in each 1 PBS group not noted on the graph. Significance determined by (A) an individual Mann-Whitney test per population, (B,E,F) goodness of fit, with R 2 and P value reported on the graph, and (D) by four pair-wise Mann-Whitney tests and the P values adjusted for multiple comparisons using the Holm-Bonferroni method as described in the Materials and Methods. *P 0.05; **P 0.01; ***P 0.001; ****P 0.0001; nonsignificance represented by absence of bar. Abbreviations: B6, C57BL/6J; DT, diphtheria toxin; Hepa; hepatocyte; Hprt, hypoxanthine-guanine phosphoribosyltransferase.
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hDTR mRNA confirmed that our rAAV8 vector provided liver-and hepatocyte-specific expression. In stark contrast to adenoviral vectors, the immune response to single-stranded AAV vectors is transient and mild, resolving within 6 hours following AAV injection. (17) The response is driven by TLR9-and MyD88-dependent signaling and results in a shortterm increase of infiltrating neutrophils and CD11b 1 cells and an increase in mRNA for Tnf, Ccl2, Ccl4, Ccl5, Cxcl2, and Cxcl10. (17) To assure that the initial Correlation of serum ALT levels with gene expression fold change levels for B6 1 DT (black) and TRIF -/-1 DT (white) groups. Data are combined for two to three independent experiments. Each data point represents an individual mouse (n 5 8-13 per group), bars represent the median. Significance determined by (A) four pair-wise Mann-Whitney tests and the P values adjusted for multiple comparisons using the Holm-Bonferroni method as described in the Materials and Methods and (B) goodness of fit, with R 2 and P value reported on the graph. *P 0.05; **P 0.01; ***P 0. 001; ****P 0.0001; nonsignificance represented by absence of bar. Abbreviation: B6, C57BL/6J. immune response to rAAV was no longer present and that transgene expression was stable, we allowed for 2 weeks between rAAV injection and injection of DT.
Hepatocyte death, induced by injection of DT, resulted in maximal liver damage 48 hours following DT injection and was accompanied by an increase in mRNA and protein for inflammatory mediators. This response was largely dependent upon TRIF and, to a lesser extent, also dependent on MyD88. Perhaps the most-studied liver injury driven by TRIF-dependent signaling is alcohol toxicity, where increased translocation of endotoxin from gut microbiota into the liver through the portal vein results in signaling by TLR4 in a MyD88-independent, TRIF-dependent manner. (18) (19) (20) (21) The role for TRIF signaling in other liver injury is less clear. In APAP-induced injury, TLR4 and TLR9 have been identified as key receptors involved in the recruitment of infiltrating monocytes and neutrophils and the production of IL-6, TNF-a, and IL-1b; however, the downstream signaling pathways need to be elucidated. (22) (23) (24) (25) The similarities in the inflammation profile between our model and the APAP model suggest that TRIF signaling could be important for the induction of inflammation in APAP hepatotoxicity. In a model of ischemia-reperfusion injury, TLR4
-/-mice were protected from injury, producing less Cxcl10, Icam1, Tnf, Il1b, and Ifng. (26) Furthermore, Zhai et al. reported that the DAMP high mobility group box 1 protein signaled through a MyD88-independent, IFN-regulatory factor 3-dependent route to propagate inflammation in ischemia-reperfusion injury. (27) Both of these studies suggest that TRIF may be the adaptor mediating the inflammatory responses. It should be noted that signaling by TRIF generally results in production of type I IFNs. (14) In sterile inflammation resulting from ischemia-reperfusion injury, IFNAR1-deficient mice were protected from liver damage and produced less transcript for Tnf, Il1b, Il6, Ccl2, Cxcl10, and Icam1, as well as had fewer infiltrating neutrophils and macrophages. (28) Although we observed the induction of Ifnb1 transcript following injury, liver damage in IFNAR1 -/-mice was not significantly different from that observed in wild-type mice, eliminating a role for type I IFN signaling in the pathology of hepatocyte-specific death.
Although the models discussed above are heavily dependent upon signaling through TLR4, we find that the TRIF-dependent response to hepatocyte death is independent of TLR4. In the absence of upstream signaling through TLR4, TRIF signaling is thought to be initiated by TLR3. The role of TLR3 in sterile liver injury remains relatively unknown, though studies show it contributes to liver damage in models of APAP hepatotoxicity and concanavalin A-induced hepatitis. (29, 30) Although we observed 30-fold less transduction of hepatocytes by rAAV8.mCherry.hDTR in TLR3 -/-mice when compared to wildtype mice, we could not evaluate the in vivo role of TLR3 signaling. It is possible that the lack of functional TLR3 in TLR3 -/-mice either directly affects the alternative nuclear factor kappa B (NF-jB) pathway or affects the ability of rAAV to use this pathway for transgene expression, because Jayandharan et al. demonstrated that the alternative NF-jB pathway was necessary for expression of AAV-encoded transgenes. (31) In vitro studies, which show that mRNA from necrotic cells signals through a TLR3-and TRIF-dependent pathway in dendritic cells, support the possibility that TLR3 is the receptor responding to cell death. (32) In contrast, Zhang et al. have shown that members of the DExD/H-box helicase family-DDX1, DDX21, and DHX36-signal through TRIF to induce type I IFN in response to double-stranded RNA (33) ; and, the DDX21-, TRIF-dependent signaling pathway, has been shown to play a role in Influenza A infection. (34) Our initial studies in Huh7 human hepatoma cells indicate that induction of certain inflammatory genes observed in our mouse model of hepatocyte-specific death are preserved in a system lacking TLR3 signaling, supporting a possible role for a TLR3-independent, TRIF-dependent inflammatory pathway.
The role hepatocytes play in sterile liver inflammation, and particularly in the response to hepatocyte death, is relatively unknown. Though limited data are available concerning the role of hepatocytes as drivers of an inflammatory response, in vitro studies have produced some provocative results. Primary mouse hepatocytes secrete IL-6 in response to free fatty acids and IL-17 (35) and IL-6 and TNF-a in response to free fatty acids alone. (36) In mouse models of chronic injury induced by carbon tetrachloride, CCL20 was detected in hepatocytes by immunohistochemistry (37) and secreted by murine primary hepatocytes in culture. (38) Additionally, hepatocytes isolated from ethanoltreated mice expressed more Cxcl1 than those from control mice. (39) In our model of hepatocyte-specific death, upregulation of Ccl2, Ccl5, Ccl7, Cxcl1, Cxcl2, Cxcl10, Icam1, and Vcam1 was greater in hepatocytes than in either LSECs or KCs, highlighting hepatocytes as key players in the sterile inflammatory response to hepatocyte death.
A number of studies have shown that cells undergoing apoptosis, necrosis, or necroptosis maintain the capacity to up-regulate transcription and protein production. (40) (41) (42) (43) (44) IL-6 can be secreted by necrotic cells (42) ; IL-6, CCL2, and CXCL1 secreted by apoptotic cells (43) ; and, most recently, necroptotic cells showed increased transcription of many genes, including Cxcl1, Cxcl10, Ccl2, Ccl7, and Il6. (44) Given the transcript repertoire we detected in our studies, it is possible that dying hepatocytes are producing chemokines in our model (Fig. 7A) . Alternatively, or in parallel, live hepatocytes responding to mediators produced by KCs and LSECs or sensing and responding to hepatocyte death themselves-possibly through the induction of their own death-may also be responsible for the up-regulation of these transcripts (Fig. 7B,C) . This latter possibility is supported by our observation that many of these transcripts are up-regulated in KCs and LSECs 6 hours following DT injection, indicating the induction of an innate immune response in neighboring cells. Finally, sensing and response by live hepatocytes is also supported by in vitro findings in which primary mouse hepatocytes, independent of death, increased expression for a number of inflammatory proteins, including Cxcl1, Cxcl2, Cxcl10, Ccl2, Ccl7, Ccl20, Icam1, Vcam1, Il1b, and Il10, in response to bile acids. (45) The results of our in vivo study of hepatocyte death combined with the in vitro study provide compelling evidence for a common inflammatory pathway induced in hepatocytes in response to insult, in these cases, DAMPs released from other dying hepatocytes or bile acids.
Interestingly, though we found that TRIF is the master regulator of inflammation induced by hepatocyte death, we observed breakthrough inflammation and sterile injury in a subset of TRIF -/-mice. This suggests that there are redundant pathways primed to respond to liver injury and hepatocyte death in particular. MyD88 is a clear candidate for an alternative regulator given that we saw only a partial reduction in liver injury and inflammation in MyD88 -/-mice. We speculate that in a subset of mice, the balance between the TRIF and MyD88 signaling pathways is tipped, so that the MyD88 signaling pathway is able to drive induction of transcripts for chemokines and cell adhesion molecules. Accordingly, studies in TRIF 3 MyD88 double-knockout mice would elucidate whether MyD88 is able to compensate for lack of TRIF signaling. Finally, similar to other mouse models of sterile injury, we observed an influx of neutrophils followed by an influx of monocytes to the site of injury. Our studies indicated that monocytes and neutrophils were not driving peak liver injury; however, this does not rule out a role for either population in earlier injury or later resolution. Models of acute and chronic liver injury have demonstrated complex roles for monocytes in the induction of early injury and fibrosis to the resolution of injury. (46) Most recently, CCR2 1 monocytes have been implicated in early stages of APAP-induced liver injury, whereas earlier studies indicate that infiltrating monocytes may play a role in the resolution of liver injury. (47, 48) In our model, we initially observed higher proportions of Ly6C hi monocytes, but by 72 hours, we observed higher proportions of Ly6C lo monocytes. In conjunction with the histology that indicates that hepatocytes are regenerating by 72 hours, it is possible that Ly6C hi monocytes infiltrate the liver and differentiate into Ly6C lo monocyte-derived macrophages, which contribute to tissue repair (Fig.  7D,E) . This possibility is supported by two elegant studies, which demonstrate the plasticity of monocytes and the ability of Ly6C hi monocytes to infiltrate the liver following injury and differentiate into Ly6C lo monocyte-derived macrophages that are important for injury resolution and tissue repair. (49, 50) In summary, we have identified TRIF as a central mediator in the response to hepatocyte-specific death. Hepatocytes themselves produce the most robust response to hepatocyte death through up-regulation of genes for myeloid cell-recruiting factors. In serum as a whole, we observed an increase in IL-6, IL-1b, and IL-10, which is absent in TRIF -/-mice, indicating a complete dependence on TRIF signaling for production of these inflammatory cytokines. Conversely, although the increased expression of chemokine and cell adhesion genes and proteins associated with the myeloid cell-recruiting response was reduced in a majority of TRIF -/-mice, a subset of mice was able to compensate for the lack of TRIF and induce expression of this set of factors, indicating a potential redundancy for this pathway. Finally, we found the TRIFdriven response to hepatocyte death to be independent of TLR4 and type I IFN. The relevance of these finding to human liver injury is emphasized both because parallel effects are observed in APAP toxicity, an important cause of acute liver failure, and because human Huh7 cells respond to DT-induced death by inducing many of the same genes as do mouse hepatocytes.
